These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21774711)

  • 1. Mutual antagonism of T cells causing psoriasis and atopic eczema.
    Eyerich S; Onken AT; Weidinger S; Franke A; Nasorri F; Pennino D; Grosber M; Pfab F; Schmidt-Weber CB; Mempel M; Hein R; Ring J; Cavani A; Eyerich K
    N Engl J Med; 2011 Jul; 365(3):231-8. PubMed ID: 21774711
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psoriasis or atopic eczema: skin-infiltrating effector memory T cells make the difference].
    Homey B
    Hautarzt; 2012 Jan; 63(1):52. PubMed ID: 22212158
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis.
    Moy AP; Murali M; Kroshinsky D; Duncan LM; Nazarian RM
    JAMA Dermatol; 2015 Jul; 151(7):753-60. PubMed ID: 25760640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.
    Ghoreschi K; Thomas P; Breit S; Dugas M; Mailhammer R; van Eden W; van der Zee R; Biedermann T; Prinz J; Mack M; Mrowietz U; Christophers E; Schlöndorff D; Plewig G; Sander CA; Röcken M
    Nat Med; 2003 Jan; 9(1):40-6. PubMed ID: 12461524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T-helper1/T-helper2 paradigm: still valid for drug discovery but with some essential refinement.
    Korstanje C
    Curr Opin Investig Drugs; 2004 May; 5(5):487-8. PubMed ID: 15202720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subpopulations of peripheral T lymphocytes (Th/Ts) in atopic dermatitis and in psoriasis].
    Klene U; Gollnick H; Bauer R; Orfanos CE
    Hautarzt; 1986 Jan; 37(1):17-22. PubMed ID: 2936698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.
    Neis MM; Peters B; Dreuw A; Wenzel J; Bieber T; Mauch C; Krieg T; Stanzel S; Heinrich PC; Merk HF; Bosio A; Baron JM; Hermanns HM
    J Allergy Clin Immunol; 2006 Oct; 118(4):930-7. PubMed ID: 17030248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
    Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
    Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: A retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis.
    Cohen JN; Bowman S; Laszik ZG; North JP
    J Am Acad Dermatol; 2020 Feb; 82(2):430-439. PubMed ID: 31859047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis.
    Breuer K; Wittmann M; Kempe K; Kapp A; Mai U; Dittrich-Breiholz O; Kracht M; Mrabet-Dahbi S; Werfel T
    Clin Exp Allergy; 2005 Aug; 35(8):1088-95. PubMed ID: 16120092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease.
    Hren MG; Guenin S; Khattri S
    J Am Acad Dermatol; 2024 Jul; 91(1):138-140. PubMed ID: 38494153
    [No Abstract]   [Full Text] [Related]  

  • 12. Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
    Wolk K; Mitsui H; Witte K; Gellrich S; Gulati N; Humme D; Witte E; Gonsior M; Beyer M; Kadin ME; Volk HD; Krueger JG; Sterry W; Sabat R
    Clin Cancer Res; 2014 Nov; 20(21):5507-16. PubMed ID: 25212608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.
    Eyerich K; Novak N
    Allergy; 2013 Aug; 68(8):974-82. PubMed ID: 23889510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
    Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
    Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra domain A-positive fibronectin-positive feedback loops and their association with cutaneous inflammatory disease.
    McFadden JP; Basketter DA; Dearman RJ; Kimber IR
    Clin Dermatol; 2011; 29(3):257-65. PubMed ID: 21496732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 4 treatment of psoriasis: are pleiotropic cytokines suitable therapies for autoimmune diseases?
    Martin R
    Trends Pharmacol Sci; 2003 Dec; 24(12):613-6. PubMed ID: 14654299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes.
    Yasukawa S; Dainichi T; Kokuba H; Moroi Y; Urabe K; Hashimoto T; Furue M
    Eur J Dermatol; 2009; 19(1):69-71. PubMed ID: 19059833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-helper immune phenotype may underlie 'paradoxical' tumour necrosis factor-α inhibitor therapy-related psoriasiform dermatitis.
    Moy AP; Murali M; Kroshinsky D; Horn TD; Nazarian RM
    Clin Exp Dermatol; 2018 Jan; 43(1):19-26. PubMed ID: 28940220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psoriasis syndrome with its comorbidities].
    Piérard-Franchimont C; Piérard GE; Delvenne P; Hermanns-Lê T
    Rev Med Liege; 2014 Oct; 69(10):555-8. PubMed ID: 25796750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of atopic dermatitis symptoms by ustekinumab in psoriatic patients with elevated serum immunoglobulin E levels: Report of two cases.
    Ishiuji Y; Umezawa Y; Asahina A; Fukuta H; Aizawa N; Yanaba K; Nakagawa H
    J Dermatol; 2018 Jun; 45(6):732-734. PubMed ID: 29569296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.